首页> 美国卫生研究院文献>Cardiovascular Research >Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis
【2h】

Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis

机译:Noggin减弱主动脉瓣硬化中人瓣膜间质细胞的成骨激活

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AimsAortic valve sclerosis (AVSc) is a hallmark of several cardiovascular conditions ranging from chronic heart failure and myocardial infarction to calcific aortic valve stenosis (AVS). AVSc, present in 25–30% of patients over 65 years of age, is characterized by thickening of the leaflets with marginal effects on the mechanical proprieties of the valve making its presentation asymptomatic. Despite its clinical prevalence, few studies have investigated the pathogenesis of this disease using human AVSc specimens. Here, we investigate in vitro and ex vivo BMP4-mediated transdifferentiation of human valve interstitial cells (VICs) towards an osteogenic-like phenotype in AVSc.
机译:Aims主动脉瓣硬化症(AVSc)是几种心血管疾病的标志,从慢性心力衰竭,心肌梗塞到钙化主动脉瓣狭窄(AVS)。 AVSc在65岁以上的患者中占25–30%,其特征是小叶增厚,对瓣膜的机械特性有轻微的影响,使其无症状。尽管其临床盛行,但很少有研究使用人类AVSc标本研究这种疾病的发病机理。在这里,我们研究了体外和离体BMP4介导的人瓣膜间质细胞(VIC)向AVSc中成骨样表型的转分化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号